Daito Chemix Corporation (TYO:4366)
Japan · Delayed Price · Currency is JPY 408.00
-1.00 (-0.24%)
Feb 13, 2026, 3:30 PM JST
Daito Chemix Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 18,976 | 18,644 | 15,811 | 16,377 | 16,134 | 13,998 | |
Revenue Growth (YoY) | 3.10% | 17.92% | -3.46% | 1.51% | 15.26% | 12.73% |
Cost of Revenue | 16,762 | 16,571 | 13,911 | 13,942 | 13,205 | 11,496 |
Gross Profit | 2,214 | 2,073 | 1,900 | 2,435 | 2,929 | 2,502 |
Selling, General & Admin | 1,231 | 1,139 | 1,033 | 1,037 | 1,051 | 964 |
Research & Development | 40 | 40 | 44 | 45 | 45 | 27 |
Operating Expenses | 1,317 | 1,225 | 1,124 | 1,150 | 1,165 | 1,058 |
Operating Income | 897 | 848 | 776 | 1,285 | 1,764 | 1,444 |
Interest Expense | -63 | -47 | -39 | -41 | -21 | -20 |
Interest & Investment Income | 67 | 58 | 56 | 46 | 37 | 35 |
Earnings From Equity Investments | 17 | -14 | -1,506 | 21 | -21 | -271 |
Currency Exchange Gain (Loss) | -32 | -38 | -18 | -31 | -18 | 2 |
Other Non Operating Income (Expenses) | 22 | 21 | 23 | 27 | 42 | 41 |
EBT Excluding Unusual Items | 908 | 828 | -708 | 1,307 | 1,783 | 1,231 |
Gain (Loss) on Sale of Investments | - | - | 73 | - | - | - |
Gain (Loss) on Sale of Assets | -12 | -9 | -24 | -17 | -32 | - |
Legal Settlements | -8 | - | - | - | - | - |
Other Unusual Items | 137 | 34 | -19 | - | - | - |
Pretax Income | 1,025 | 853 | -678 | 1,290 | 1,751 | 1,231 |
Income Tax Expense | 185 | 33 | 327 | 368 | 168 | 139 |
Net Income | 840 | 820 | -1,005 | 922 | 1,583 | 1,092 |
Net Income to Common | 840 | 820 | -1,005 | 922 | 1,583 | 1,092 |
Net Income Growth | - | - | - | -41.76% | 44.96% | 108.40% |
Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Change (YoY) | -0.00% | - | - | - | - | - |
EPS (Basic) | 26.08 | 25.46 | -31.21 | 28.63 | 49.15 | 33.91 |
EPS (Diluted) | 26.08 | 25.46 | -31.21 | 28.63 | 49.15 | 33.91 |
EPS Growth | - | - | - | -41.76% | 44.96% | 108.40% |
Free Cash Flow | - | 1,862 | -1,655 | -1,500 | -319 | 2,138 |
Free Cash Flow Per Share | - | 57.82 | -51.39 | -46.58 | -9.90 | 66.39 |
Dividend Per Share | 3.667 | 5.333 | 3.333 | 4.000 | 4.667 | 4.000 |
Dividend Growth | 10.00% | 60.00% | -16.67% | -14.29% | 16.67% | 50.00% |
Gross Margin | 11.67% | 11.12% | 12.02% | 14.87% | 18.15% | 17.87% |
Operating Margin | 4.73% | 4.55% | 4.91% | 7.85% | 10.93% | 10.32% |
Profit Margin | 4.43% | 4.40% | -6.36% | 5.63% | 9.81% | 7.80% |
Free Cash Flow Margin | - | 9.99% | -10.47% | -9.16% | -1.98% | 15.27% |
EBITDA | 2,371 | 2,325 | 2,257 | 2,083 | 2,361 | 2,046 |
EBITDA Margin | 12.50% | 12.47% | 14.27% | 12.72% | 14.63% | 14.62% |
D&A For EBITDA | 1,474 | 1,477 | 1,481 | 798 | 597 | 602 |
EBIT | 897 | 848 | 776 | 1,285 | 1,764 | 1,444 |
EBIT Margin | 4.73% | 4.55% | 4.91% | 7.85% | 10.93% | 10.32% |
Effective Tax Rate | 18.05% | 3.87% | - | 28.53% | 9.59% | 11.29% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.